Telemetry Investments’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Telemetry Investments’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-18,190	Closed	-$75K	–	157
2017 Q1	$75K	Sell	18,190 -3,310	-15%	-$13.9K	0.08%	113
2016 Q4	$93K	Sell	21,500 -2,167	-9%	-$14K	0.12%	100
2016 Q3	$233K	Sell	23,667 -18,000	-43%	-$128K	0.27%	77
2016 Q2	$236K	Sell	41,667 -4,333	-9%	-$29.4K	0.26%	82
2016 Q1	$351K	Sell	46,000 -4,000	-8%	-$30.8K	0.31%	73
2015 Q4	$666K	Buy	50,000 +10,083	+25%	+$174K	0.42%	69
2015 Q3	$656K	Sell	39,917 -5,916	-13%	-$121K	0.36%	78
2015 Q2	$1.03M	Buy	45,833 +4,166	+10%	+$65.9K	0.65%	49
2015 Q1	$408K	Buy	41,667 +15,750	+61%	+$154K	0.31%	85
2014 Q4	$295K	Buy	+25,917	New	+$281K	0.21%	125

Other funds holding CASC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return